… to evaluate the effect of neoadjuvant chemotherapy on the survival of patients with oropharyngeal
cancer. Patients with a squamous cell carcinoma of the oropharynx for whom curative …

… neoadjuvant chemotherapy arm.14 In our study of a fairly uniform group of p16 positive
oropharyngeal cancers, neoadjuvant chemotherapy … escalation (neoadjuvant chemotherapy) with …

… the planned three cycles of chemotherapy, 37% of … chemotherapy regimen, also failed
to show a benefit for induction therapy. In this study, locally advanced resectable oral cancer …

… oropharyngeal cancer. Flowchart of patients diagnosed with p16 positive oropharynx cancer
at our … ECOG, Eastern Cooperative Oncology Group; NAC + S, neoadjuvant chemotherapy …

… The purpose of this study was to present our evaluation of the outcome of oropharyngeal
cancer managed with neoadjuvant chemotherapy and transoral surgery (TOS) with neck …

… human papillomavirus virus−associated oropharyngeal squamous cell carcinoma (HPV-OPSCC)
to … Treatment with neoadjuvant chemotherapy followed by TORS and neck dissection (…

… , we aimed to determine if neoadjuvant chemotherapy alone can lead to the measurable
induction of HPV-specific T cell immunity at the primary tumor site. Our observations indicate …

… for patients with locally advanced oropharyngeal cancer. Although future large-… neoadjuvant
chemotherapy combined with TORS is useful for treating advanced oropharyngeal cancer…

… Even the GETTEC investigators concluded that the evidence was not convincing enough
to establish neoadjuvant chemotherapy as a standard treatment [12•]. It is unknown whether …

… and neck carcinoma were randomly assigned to receive four cycles of neoadjuvant chemotherapy
… Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French …